Bryologyx

0 followers

‌

BryoLogyx is developing a new class of drugs to enhance the response rates and treatment durability of cancer immunotherapies.

Industries

Headquarters

Employees

Links

Org chart

Co-Founder, CEO & Director

Thomas M. Loarie

Collapse

CFO

General Counsel

VP, Clinical Development & Logistics

Director, Pharmaceutical Development

Senior Scientist, Immunology

9 members

6 members

5 members

Thermo Fisher Scientific

136 followers

Genentech

142 followers

Gilead Sciences

118 followers

Biogen

106 followers

Regeneron

86 followers

Discover companies